Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

CCR10+ ILC2s with ILC1-like properties exhibit a protective function in severe allergic asthma.

Beuraud C, Lombardi V, Luce S, Horiot S, Naline E, Neukirch C, Airouche S, Perchet T, Golub R, Devillier P, Chollet-Martin S, Baron-Bodo V, Nony E, Aubier M, Mascarell L, Moingeon P.

Allergy. 2018 Nov 26. doi: 10.1111/all.13679. [Epub ahead of print]

PMID:
30475388
2.

The house dust mite allergen Der p 5 binds lipid ligands and stimulates airway epithelial cells through a TLR2-dependent pathway.

Pulsawat P, Soongrung T, Satitsuksanoa P, Le Mignon M, Khemili S, Gilis D, Nony E, Kennedy MW, Jacquet A.

Clin Exp Allergy. 2019 Mar;49(3):378-390. doi: 10.1111/cea.13278. Epub 2018 Oct 12.

PMID:
30230051
3.

The Bioavailability of Allergens in Allergy Tablets Depends on Several Factors.

Mascarell L, Batard T, Cuiné JF, Nony E.

Int Arch Allergy Immunol. 2018;175(4):252-253. doi: 10.1159/000486960. Epub 2018 Feb 7. No abstract available.

PMID:
29414826
4.

The Blomia tropicalis allergen Blo t 7 stimulates innate immune signalling pathways through TLR2.

Soongrung T, Mongkorntanyatip K, Peepim T, Buaklin A, Le Mignon M, Malainual N, Nony E, Jacquet A.

Clin Exp Allergy. 2018 Apr;48(4):464-474. doi: 10.1111/cea.13098. Epub 2018 Feb 22.

PMID:
29356186
5.

Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.

Brier S, Le Mignon M, Jain K, Lebrun C, Peurois F, Kellenberger C, Bordas-Le Floch V, Mascarell L, Nony E, Moingeon P.

Allergy. 2018 May;73(5):1032-1040. doi: 10.1111/all.13364. Epub 2017 Dec 12.

PMID:
29171882
6.

Validation of ELISA methods for quantification of the major birch allergen Bet v 1 (BSP090).

Kaul S, Zimmer J, Dehus O, Constanzo A, Daas A, Buchheit KH, Asturias J, Arilla MC, Barber D, Bertocchi A, Brunetto B, Carnes JA, Chapman M, Chaudemanche G, Dayan-Kenigsberg J, Döring S, Führer F, Gallego MT, Iacovacci P, Hanschmann KM, Holzhauser T, Hrabina M, Ledesma A, Moingeon P, Nony E, Pini C, Plunkett G, Raulf M, Reese G, Sandberg E, Sander I, Smith B, Strecker D, Valerio C, van Ree R, Weber B, Vieths S.

Pharmeur Bio Sci Notes. 2017;2017:69-87.

PMID:
29143737
7.

A combined transcriptome and proteome analysis extends the allergome of house dust mite Dermatophagoides species.

Bordas-Le Floch V, Le Mignon M, Bussières L, Jain K, Martelet A, Baron-Bodo V, Nony E, Mascarell L, Moingeon P.

PLoS One. 2017 Oct 5;12(10):e0185830. doi: 10.1371/journal.pone.0185830. eCollection 2017.

8.

Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapy.

Caillot N, Bouley J, Jain K, Mariano S, Luce S, Horiot S, Airouche S, Beuraud C, Beauvallet C, Devillier P, Chollet-Martin S, Kellenberger C, Mascarell L, Chabre H, Batard T, Nony E, Lombardi V, Baron-Bodo V, Moingeon P.

J Allergy Clin Immunol. 2017 Sep;140(3):759-770.e13. doi: 10.1016/j.jaci.2016.10.036. Epub 2016 Dec 10.

PMID:
27965111
9.

Bioinspired Design and Oriented Synthesis of Immunogenic Site-Specifically Penicilloylated Peptides.

Scornet N, Delarue-Cochin S, Azoury ME, Le Mignon M, Chemelle JA, Nony E, Maillère B, Terreux R, Pallardy M, Joseph D.

Bioconjug Chem. 2016 Nov 16;27(11):2629-2645. Epub 2016 Sep 9.

PMID:
27552359
10.

Proteomics for Allergy: from Proteins to the Patients.

Nony E, Le Mignon M, Brier S, Martelet A, Moingeon P.

Curr Allergy Asthma Rep. 2016 Sep;16(9):64. doi: 10.1007/s11882-016-0642-5. Review.

PMID:
27534655
11.

Allergen immunotherapy for birch pollen-allergic patients: recent advances.

Moingeon P, Floch VB, Airouche S, Baron-Bodo V, Nony E, Mascarell L.

Immunotherapy. 2016 May;8(5):555-67. doi: 10.2217/imt-2015-0027. Review.

PMID:
27140409
12.

The minor house dust mite allergen Der p 13 is a fatty acid-binding protein and an activator of a TLR2-mediated innate immune response.

Satitsuksanoa P, Kennedy M, Gilis D, Le Mignon M, Suratannon N, Soh WT, Wongpiyabovorn J, Chatchatee P, Vangveravong M, Rerkpattanapipat T, Sangasapaviliya A, Piboonpocanun S, Nony E, Ruxrungtham K, Jacquet A; Mite Allergy Research Cohort (MARC) study team.

Allergy. 2016 Oct;71(10):1425-34. doi: 10.1111/all.12899. Epub 2016 Apr 29.

PMID:
27018864
13.

Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1.

Kaul S, Zimmer J, Dehus O, Costanzo A, Daas A, Buchheit KH, Asturias JA, Barber D, Carnés J, Chapman M, Dayan-Kenigsberg J, Döring S, Führer F, Hanschmann KM, Holzhauser T, Ledesma A, Moingeon P, Nony E, Pini C, Plunkett G, Reese G, Sandberg E, Sander I, Strecker D, Valerio C, van Ree R, Vieths S.

Allergy. 2016 Oct;71(10):1414-24. doi: 10.1111/all.12898. Epub 2016 Apr 28.

PMID:
27018782
14.

The House Dust Mite Major Allergen Der p 23 Displays O-Glycan-Independent IgE Reactivities but No Chitin-Binding Activity.

Soh WT, Le Mignon M, Suratannon N, Satitsuksanoa P, Chatchatee P, Wongpiyaboron J, Vangveravong M, Rerkpattanapipat T, Sangasapaviliya A, Nony E, Piboonpocanun S, Ruxrungtham K, Jacquet A; Mite Allergy Research Cohort (MARC) Study Team.

Int Arch Allergy Immunol. 2015;168(3):150-60. doi: 10.1159/000442176. Epub 2016 Jan 21.

15.

Allergen extracts for immunotherapy: to mix or not to mix?

Nony E, Martelet A, Jain K, Moingeon P.

Expert Rev Clin Pharmacol. 2016;9(3):401-8. doi: 10.1586/17512433.2015.1131122. Epub 2016 Jan 8. Review.

PMID:
26652799
16.

Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy.

Gueguen C, Bouley J, Moussu H, Luce S, Duchateau M, Chamot-Rooke J, Pallardy M, Lombardi V, Nony E, Baron-Bodo V, Mascarell L, Moingeon P.

J Allergy Clin Immunol. 2016 Feb;137(2):545-58. doi: 10.1016/j.jaci.2015.09.015. Epub 2015 Oct 29.

PMID:
26522402
17.

Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.

Batard T, Baron-Bodo V, Martelet A, Le Mignon M, Lemoine P, Jain K, Mariano S, Horiot S, Chabre H, Harwanegg C, Marquette CA, Corgier BP, Soh WT, Satitsuksanoa P, Jacquet A, Chew FT, Nony E, Moingeon P.

Allergy. 2016 Feb;71(2):220-9. doi: 10.1111/all.12796. Epub 2015 Nov 13.

PMID:
26485347
18.

New insights into ragweed pollen allergens.

Bordas-Le Floch V, Groeme R, Chabre H, Baron-Bodo V, Nony E, Mascarell L, Moingeon P.

Curr Allergy Asthma Rep. 2015 Nov;15(11):63. doi: 10.1007/s11882-015-0565-6. Review.

PMID:
26383916
19.

Identification of Novel Short Ragweed Pollen Allergens Using Combined Transcriptomic and Immunoproteomic Approaches.

Bordas-Le Floch V, Le Mignon M, Bouley J, Groeme R, Jain K, Baron-Bodo V, Nony E, Mascarell L, Moingeon P.

PLoS One. 2015 Aug 28;10(8):e0136258. doi: 10.1371/journal.pone.0136258. eCollection 2015.

20.

Identification of the cysteine protease Amb a 11 as a novel major allergen from short ragweed.

Bouley J, Groeme R, Le Mignon M, Jain K, Chabre H, Bordas-Le Floch V, Couret MN, Bussières L, Lautrette A, Naveau M, Baron-Bodo V, Lombardi V, Mascarell L, Batard T, Nony E, Moingeon P.

J Allergy Clin Immunol. 2015 Oct;136(4):1055-64. doi: 10.1016/j.jaci.2015.03.001. Epub 2015 Apr 10.

PMID:
25865353
21.

Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients.

Nony E, Bouley J, Le Mignon M, Lemoine P, Jain K, Horiot S, Mascarell L, Pallardy M, Vincentelli R, Leone P, Roussel A, Batard T, Abiteboul K, Robin B, de Beaumont O, Arvidsson M, Rak S, Moingeon P.

Allergy. 2015 Jul;70(7):795-804. doi: 10.1111/all.12622. Epub 2015 Apr 20.

PMID:
25846209
22.

Specific IgE recognition of pollen allergens from subtropic grasses in patients from the subtropics.

Nony E, Timbrell V, Hrabina M, Boutron M, Solley G, Moingeon P, Davies JM.

Ann Allergy Asthma Immunol. 2015 Mar;114(3):214-220.e2. doi: 10.1016/j.anai.2014.12.005.

PMID:
25744907
23.

Characterization of the house dust mite allergen Der p 21 produced in Pichia pastoris.

Pulsawat P, Theeraapisakkun M, Nony E, Le Mignon M, Jain K, Buaklin A, Wongpiyabovorn J, Ruxrungtham K, Jacquet A.

Protein Expr Purif. 2014 Sep;101:8-13. doi: 10.1016/j.pep.2014.05.001. Epub 2014 May 27.

PMID:
24874917
24.

Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma.

Tourdot S, Airouche S, Berjont N, Moussu H, Betbeder D, Nony E, Bordas-Le Floch V, Baron-Bodo V, Mascarell L, Moingeon P.

Vaccine. 2013 May 28;31(23):2628-37. doi: 10.1016/j.vaccine.2013.03.041. Epub 2013 Apr 10.

PMID:
23583462
25.

Quality control of house dust mite extracts for allergen immunotherapy.

Moingeon P, Batard T, Nony E, Hrabina M, Frati F.

Int Arch Allergy Immunol. 2013;161(3):285-6. doi: 10.1159/000347045. Epub 2013 Mar 15. No abstract available.

PMID:
23548609
26.

Molecular and functional characterization of natural allergen extracts.

Batard T, Nony E, Chabre H, Hrabina M, Bouley J, Lemignon M, Lemoine P, Jain K, Tourdot S, Mascarell L, Bodo V, Moingeon P.

Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2013;97:54-6. No abstract available.

PMID:
24912313
27.

Advances in the quantification of relevant allergens in allergenic extracts.

Batard T, Nony E, Hrabina M, Chabre H, Frati F, Moingeon P.

Eur Ann Allergy Clin Immunol. 2013 Oct 1;45 Suppl 2:33-7.

PMID:
24129086
28.

Anti-inflammatory activity of sublingual immunoglobulin (SLIG) in a murine model of allergen-driven airway inflammation.

Batard T, Zimmer A, Nony E, Bouley J, Airouche S, Luce S, Turfkruyer M, Tourdot S, Mascarell L, Moingeon P.

Vaccine. 2012 Aug 17;30(38):5666-74. doi: 10.1016/j.vaccine.2012.06.049. Epub 2012 Jul 7.

PMID:
22776213
29.

A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy.

Zimmer A, Bouley J, Le Mignon M, Pliquet E, Horiot S, Turfkruyer M, Baron-Bodo V, Horak F, Nony E, Louise A, Moussu H, Mascarell L, Moingeon P.

J Allergy Clin Immunol. 2012 Apr;129(4):1020-30. doi: 10.1016/j.jaci.2012.02.014.

PMID:
22464673
30.

Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapy.

Bordas-Le Floch V, Bussières L, Airouche S, Lautrette A, Bouley J, Berjont N, Horiot S, Huet A, Jain K, Lemoine P, Chabre H, Batard T, Mascarell L, Baron-Bodo V, Tourdot S, Nony E, Moingeon P.

Int Arch Allergy Immunol. 2012;158(2):157-67. doi: 10.1159/000331143. Epub 2012 Jan 25.

31.

Glycoproteins are species-specific markers and major IgE reactants in grass pollens.

Manduzio H, Fitchette AC, Hrabina M, Chabre H, Batard T, Nony E, Faye L, Moingeon P, Gomord V.

Plant Biotechnol J. 2012 Feb;10(2):184-94. doi: 10.1111/j.1467-7652.2011.00654.x. Epub 2011 Sep 23.

32.

Identification of a new phenotype of tolerogenic human dendritic cells induced by fungal proteases from Aspergillus oryzae.

Zimmer A, Luce S, Gaignier F, Nony E, Naveau M, Biola-Vidamment A, Pallardy M, Van Overtvelt L, Mascarell L, Moingeon P.

J Immunol. 2011 Apr 1;186(7):3966-76. doi: 10.4049/jimmunol.1003184. Epub 2011 Mar 2.

33.

Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus.

Bussières L, Bordas-Le Floch V, Bulder I, Chabre H, Nony E, Lautrette A, Berrouet C, Nguefeu Y, Horiot S, Baron-Bodo V, Van Overtvelt L, De Conti AM, Schlegel A, Maguet N, Mouz N, Lemoine P, Batard T, Moingeon P.

Int Arch Allergy Immunol. 2010;153(2):141-51. doi: 10.1159/000312631. Epub 2010 Apr 21.

PMID:
20407270
34.

Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy.

Chabre H, Gouyon B, Huet A, Baron-Bodo V, Nony E, Hrabina M, Fenaille F, Lautrette A, Bonvalet M, Maillère B, Bordas-Le Floch V, Van Overtvelt L, Jain K, Ezan E, Batard T, Moingeon P.

Clin Exp Allergy. 2010 Mar;40(3):505-19. doi: 10.1111/j.1365-2222.2009.03380.x. Epub 2009 Nov 5. Erratum in: Clin Exp Allergy. 2010 Mar;40(3):517. Boran-Bodo, V [corrected to Baron-Bodo, V].

PMID:
19895591
35.

Mass spectrometric investigation of molecular variability of grass pollen group 1 allergens.

Fenaille F, Nony E, Chabre H, Lautrette A, Couret MN, Batard T, Moingeon P, Ezan E.

J Proteome Res. 2009 Aug;8(8):4014-27. doi: 10.1021/pr900359p.

PMID:
19572759
36.

Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation.

Himly M, Nony E, Chabre H, Van Overtvelt L, Neubauer A, van Ree R, Buchheit KH, Vieths S, Moingeon P, Ferreira F.

Allergy. 2009 Jul;64(7):1038-45. doi: 10.1111/j.1398-9995.2009.01957.x. Epub 2009 Jan 31.

PMID:
19183416
37.

Application of proteomics for the characterization of biological allergen extracts.

Batard T, Chabre H, Gouyon B, Nony E, Hrabina M, Jain K, Couret MN, Brochier V, Beauvallet C, Chew FT, Moingeon P.

Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009;96:55-9; discussion 59-60. No abstract available.

PMID:
20799445
38.

Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions.

Sibéril S, de Romeuf C, Bihoreau N, Fernandez N, Meterreau JL, Regenman A, Nony E, Gaucher C, Glacet A, Jorieux S, Klein P, Hogarth MP, Fridman WH, Bourel D, Béliard R, Teillaud JL.

Clin Immunol. 2006 Feb-Mar;118(2-3):170-9. Epub 2005 Dec 5.

PMID:
16332457
39.

Transient induction of a peroxidase gene in Medicago truncatula precedes infection by Rhizobium meliloti.

Cook D, Dreyer D, Bonnet D, Howell M, Nony E, VandenBosch K.

Plant Cell. 1995 Jan;7(1):43-55.

Supplemental Content

Support Center